Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: Results from the COMET study
Rheumatology, 08/21/09
Anis A et al. – Study demonstrates that early treatment with etanercept (ETN) + MTX led to a significant attenuation of absenteeism among patients with early active rheumatoid arthritis (RA). These productivity gains represent benefit beyond the traditional measures of clinical and radiographic improvements.
Methods- A comparison of the impact of the combination of ETN and MTX with MTX alone on work productivity among MTX-naïve pts with active early RA over a 12-mo period
- The COMET (COmbination of Methotrexate and ETanercept) trial was a 2-year double-blind randomized clinical trial
- Absenteeism during the first year was measured and it included:
- Number of missed workdays
- Reduced working time, and
- Number of stopped workdays
- Each absenteeism measure was estimated using a mixed model; their variations estimated by bootstrapping
- As a sensitivity analysis, the lost workdays due to presenteeism (reduced performance at work) was also estimated
- 205 pts (MTX: n=100 vs ETN + MTX: n=105), who were working full time or part time at baseline and had at least one f/u observation
- Compared with the MTX group, the ETN + MTX group had a max of 37 fewer missed workdays or at minimum 22 fewer missed workdays
- The associated productivity gain equalled £2586 and £1555, respectively
- When additionally accounting for presenteeism, the total improvement could be as high as 42 fewer lost workdays representing a productivity gain of £2968
Related Articles
Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study
Zeitschrift für Rheumatologie, 10/07/09
Relevance Score: 89%
Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy
Rheumatology International, 10/21/09
Relevance Score: 87%
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis
Arthritis Care and Research, 11/02/09
Relevance Score: 82%
Reversible Methotrexate-Associated Lymphoproliferative Disorder Resembling Advanced Gastric Cancer in a Patient With Rheumatoid Arthritis
The American Journal of the Medical Sciences, 10/14/09
Relevance Score: 82%
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
Rheumatology, 10/08/09
Relevance Score: 82%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/08/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/08/09
Silica exposure among male current smokers is associated with a high risk of developing ACPA positive rheumatoid arthritis
Annals of Rheumatic Diseases, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


